1.	Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CSOM230B2412, NCT01794793
2.	Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients Phase: Phase III Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
3.	Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers Phase: Phase II, Phase I Type: Tissue collection/Repository Status: Active Age: Not specified Sponsor: Other Protocol IDs: 93-102, NCT00579163
4.	External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: IOSI-RO0402, RO0402, NCT00637637
5.	Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-03112, 050909, U01CA132194, CINJ-050801, 050801, 0220080281, NCT00813423
6.	Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: HNO-FDG-FU, NCT00180245
7.	Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Active Age: 7 and over Sponsor: NCI Protocol IDs: 090242, 09-C-0242, NCT01005654
8.	Observation of Histological Changes in Parathyroid Adenomas Following High Intensity Focused Ultrasound (HIFU) Treatment Procedure Phase: No phase specified Type: Natural history/Epidemiology Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HIFU/F/12.02, NCT01060982
9.	Evaluation of a New CZT System Phase: No phase specified Type: Diagnostic Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: TASMC-10-EES-0649-CTIL, NCT01084356
10.	Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma Phase: No phase specified Type: Diagnostic Status: Approved-not yet active Age: 18 to 80 Sponsor: Other Protocol IDs: choline2010-HMO-CTIL, NCT01221896
11.	High Intensity Focused Ultrasound (HIFU) for Parathyroid Adenoma Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HIFU-PT-2010-01, NCT01291498
12.	Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas Phase: No phase specified Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 51415, NCT01574287
13.	Assessing the Patient Experience in Cancer Care Phase: No phase specified Type: Natural history/Epidemiology Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-006682, R01AT006515, NCT01621295
14.	Differentially Expressed Proteins in Sporadic Parathyroid Tumors Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Active Age: 15 to 65 Sponsor: Other Protocol IDs: parathyroid tumorigenesis, NCT01647503
15.	Tumor Bank for Blood Samples Phase: No phase specified Type: Tissue collection/Repository Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EK 366/2003, NCT01763125